Another well-known issue of PI3K/AKT SNIs is emergence of treatment-induced hyperglycaemia and hyperinsulinemia, which are propagated as ‘on-target, off tumour’ effects where blockade of PI3K/AKT/GLUT4 signalling prevents glucose uptake by peripheral tissues [19]. This evidence concerns the gene AKT1 and Hyperinsulinemia.